Project Details
| Status | Active |
|---|---|
| Effective start/end date | 25/03/26 → 25/03/31 |
Clinical Trial Phase
- Phase II
- External Sponsor
Evolve 02: A Phase II, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination with Anti-cancer Agents in Participants with Advanced/Metastatic Solid Tumors
- Arulananda, Surein (Primary Chief Investigator (PCI))
Project: Research